Reactivity and biological importance of the disulfide bonds in human growth hormone  by Gráf, L. et al.
Volume 66, number 2 FEBS LETTERS July 1976 
REACTIVITY AND BIOLOGICAL IMPORTANCE OF THE DISULFIDE BONDS 
IN HUMAN GROWTH HORMONE 
L. GRAF, J. BORVENDI~G, E. BARAT, I. HERMANN and A. PATTHY 
Research Institute for Pharmaceutical Chemistry, 1325, Budapest, P.O. Box 82, Hungary 
Received 19 March 1976 
1. Introduction 
Different methods have been reported for com- 
plete reduction and alkylation of the two disulfide 
bonds in the structure of human growth hormone 
(HGH) [1-4]. More recent studies on partial reduc- 
tion and alkylation of the disulfide bonds in porcine 
[5], human [6] and bovine growth hormones [7] 
indicated that the small disulfide loop near the COOH- 
terminus in these hormones i much more exposed to 
reducing agents than the large loop. It has been 
reported that the completely reduced and carbamido- 
methylated derivative of HGH retains the full biolo- 
gical potency of the native hormone [1-4], whereas 
complete reduction and carboxymethylation of the 
disulfide bonds in HGH leads to a considerable loss 
of the biological activities [4]. In view of this latter 
observation it has been of interest to attempt the 
selective reduction and carboxymethylation of the 
COOH-terminal disulfide loop of HGH, and to 
determine the effect of this modification the 
biological properties of HGH. In this paper we report 
the preparation and characterization f reduced 
di-S(182,189)-carboxymethylated HGH. 
2. Experimental 
2.1. Materials 
HGH was prepared by the method of Gr~if et al. 
[8]. [2-14C]bromoacetic a id (5.73 mCi/mmol) was 
prepared in the isotope laboratory of our institute. 
Dithiothreitol, iodoacetic acid, iodoacetamide and 
trypsin were obtained from Calbiochem. 
2.2. Reduction and carboxymethylation of  HGH; 
reactivity of  disulfide bonds 
HGH was reduced with different molar excesses of 
dithiothreitol ver protein cystine content in 0.1 M 
Tris buffer, pH 8.3, in the presence or absence of 
8 M urea under nitrogen at room temperature for 
40 min with a protein concentration f 5 mg/ml. 
Alkylation was carried out under the same conditions 
for 10 min by adding [2-~4C]bromoacetate in 10-fold 
molar amount o dithiothreitol. The reaction mixture 
was extensively dialysed against distilled water, and 
then freeze dried. 
The degree of reduction and carboxymethylation 
of the disulfide bonds was assessed byacid hydrolysis 
(6 M HC1, 24 h, 110°C, sealed, evacuated tubes) and 
amino acid analysis carried out in a JEOL (JLC-5AH) 
amino acid analyzer. 
The reduced and carboxymethylated d rivatives of 
HGH were digested with trypsin in 0.05 M ammonium 
acetate buffer, pH 7.5, with an enzyme to protein 
ratio of 1:50 (w/w) at 37°C for 2 h. Two mg samples 
of the hydrolysates were mapped by two-dimensional 
high voltage paper electrophoresis, fLrst at pH 5.0 
(pyridine-acetic a id-water, 10:10:1000 by vol), and 
then at pH 2.0 (formic acid-acetic acid-water, 
50:150:800 by vol). Radioautographs were obtained 
from the peptide maps on Forte X-ray film with an 
exposition of 60 h. Relative radioactivity of the 
fragments was estimated by densitometry of the 
radioautographs in a Zeiss (Jena) densitometer. The 
radioactive peptides were cut out from the maps and 
eluted with 0.5 M ammonium hydroxide solution. 
The dried eluates were hydrolysed for amino acid 
analysis. 
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2.3. Preparation and characterization freduced 
tetra-S- and di-S-alkylated derivatives of HGH 
Reduced and tetra-S-carboxymethylated nd 
tetra-S-carbamidomethylated derivatives of HGH 
were prepared by two alternative procedures: (A) 
in the presence of 8 M urea as described by Dixon 
and Li [1], (B) and in the absence of urea according 
to Bewley et al. [2]. Partially reduced and carboxy- 
methylated HGH was prepared in the absence of 
urea with 4 M exce~s of dithiothreitol over the cystine 
content in HGH according to the procedure described 
in section 2.2. The product obtained was subjected to 
chromatography on a DEAE-cellulose column. 
Gel electrophoresis was performed at pH 9.0 in 
8% polyacrylamide g l by the method of Davis [9]. 
The growth promoting and prolactin activities were 
determined by the rat tibia test [10] and the 
quantitative pigeon crop-sac assay [11 ], respectively. 
3. Results 
3.1. Reactivity of the disulfide bonds in HGH 
Table 1 presents the course of reduction and 
alkylation with increasing amounts of dithiothreitol 
in the presence and in the absence of 8 M urea. It 
may be seen from table 1 that the accessibility of the 
disulfide bonds for reduction and alkylation are con- 
siderably restricted in the native conformation. To 
establish whether or not this steric hindrance of 
reduction affects the two disulfide bonds uniformly, 
a series of reduced-carboxymethylated HGH derivatives 
was digested with trypsin and mapped by two-dimen- 
sional paper electrophoresis. As an example, the radio- 
autographs obtained from two different reduced- 
carboxymethylated HGH derivatives are shown in 
fig.1. Both these derivatives were reduced-carboxy- 
methylated to 25% (containing one mole of carboxy- 
methylcysteine p r mole of HGH), one of them in 
the presence (fig.lA), the other in the absence of urea 
(fig. 1 B). In 8 M urea all the four cysteinyl peptides 
were uniformly labeled indicating anidentical or 
closely similar reactivity of the two disulfide bonds 
towards dithiothreitol (fig.lA). In the absence of 
urea most of the radioactivity was found in fragments 
C1 and C2 (fig. 1B). 
The amino acid analysis of the radioactive peptides 
gave evidence that fragments C1 and C2 are derived 
from residues 179-183 and 184-191 of the sequence, 
respectively, whereas fragments M1 and M2 came from 
sequence regions of residues 42-64 and 165-167, 
respectively (for sequence see [12]). 
The above data indicate that the disulfide bond 
between Cysls2-Cys189 is much more xposed to 
reduction than the disulfide bridge between 
Cyss3-Cys16s of the sequence. Semiquantitative 
evaluation of the radioautographs obtained from 
tryptic peptide maps of partially reduced and carboxy- 
methylated HGH derivatives prepared in the absence 
of urea with increasing amounts of dithiothreitol, 
showed that the reactivity of the COOH-terminal 
disulfide bond is five to six times higher than that of 
the other disulfide bond. 
Table 1 
Reactivity of the disulfide bonds in HGH with 
increasing amounts of dithiothreitol 
Dithiothreitol 
disulfide bond a 
Carboxymethylcysteine content b of reduced and carboxy- 
methylated HGH derivatives prepared in: 
the presence of urea the absence of urea 
1 1.0 0.2 
2 2.5 0.9 
3 3.1 1.5 
4 3.7 2.3 
6 3.9 2.8 
aMolar atio 
bMoles of carboxymethylcysteine per mole of HGH as determined by amino acid 
analysis 
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3.2. Preparation and characterization f reduced and 
di- S( 182,189)-carboxym e thylated HGH 
HGH was partially reduced with 4 M excess of 
dithiothreitol over the HGH cystine content in the 
absence of urea, and carboxymethylated as described 
in section 2.2. This product was submitted to DEAE- 
cellulose chromatography as shown in fig.2. Fig.3 shows 
the gel electrophoretic patterns of the partially reduced 
and carboxymethylated HGH (tube a), its fractions 
obtained from the DEAE-cellulose column (tubes b-d) ,  
intact HGH (tube e), and two completely reduced and 
carboxymethylated HGHs (tubes f and g). It may be 
seen in the figure that fraction 1 of  fig.2 is a mixture, 
fraction 3 is mainly composed of tetra-S-carboxy- 
methylated HGH, but fraction 2 is essentially free of 
native and tetra-S-carboxymethylated HGHs. Hence 
fraction 2 was further characterized. Its amino acid 
analysis revealed the presence of 2.2 carboxymethyl- 
cysteine per mole of HGH. Fraction 2 was shown to 
consist of  94% of di-S(182,189)-carboxymethylated 
HGH and 6% of di-S(53,165)-carboxymethylated 
HGH, as inferred from the radioautograph of its 
tryptic peptide map. 
The biological potencies of the native and different 
reduced-alkylated HGH preparations are summarized 
in table 2. 
I 
l 0 
TUBE NUMBER 
Fig.1. Radioautographs of the tryptic peptide maps of two 
partially (to 25%) reduced and earboxymethylated HGH 
derivatives prepared (A) in the presence and (B) in the 
absence of 8 M urea. 
Fig.2. Chromatography of 50 mg of partially reduced and 
carboxymethylated HGH (see section 3.2.) on DEAE- 
cellulose (15 × 1.5 cm). The column was equilibrated with 
0.05 ammonium hydrogencarbonate, pH 8.0 and the 
elution was performed by adding 0.3 M ammonium 
hydrogenearbonate, pH 8.0, to a 500 ml mixing flask 
which contained the starting buffer; tube volume, 5 ml; 
40 ml/h. The indicated fractions were pooled and lyophilized. 
The yields of fractions 1, 2 and 3 were 6.4 mg, 13.2 mg 
and 8.7 mg, resp.. 
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Fig.3. Disc electrophoresis of partially reduced and earboxymethylated HGH (a), the fractions of this preparation (fig.2), 
fraction 1 (b), fraction 2 (c), fraction 3 (d), and native HGH (e) and completely reduced and carboxymethylated HGHs prepared 
in the absence (f; see [2]) and in the presence of urea (g; see [ 1]); 60/~g samples. 
Table 2 
Biological potency of reduced and alkylated erivatives of HGH as measured by rat tibia and pigeon crop-sac assays 
Material a
Rat tibia test Pigeon crop-sac test 
Total dose Tibia width b Total dose Dry mucosal 
(~g) fam) fag) weight b (rag) 
Saline 0 
HGH 25 
50 
di-S(182,189)-carboxymethylated HGH 25 
50 
tetra-S-carboxymethylated HGH [1 ] 50 
150 
tetra-S-carbamidomethylated HGH [ 1 ] 25 
50 
tetra-S-carboxymethylated HGH [2] 25 
50 
100 
154-+ 2 (6) 0 9.0-+ 2.0 (6) 
195 ± 6 (5) 4 16.1 -+ 2.1 (6) 
253-+.3 (5) 10 20.1 -+ 1.9 (6) 
25 22.7 -+ 1.9 (5) 
205 ~ 8 (6) 4 17.8 -+ 3.0 (4) 
235 ~ 6 (6) 25 21.0 +- 1.4 (4) 
147 -+ 5 (5) Not measured 
160-+ 9 (4) 
190-+ 5 (5) 4 15.6 -+ 2.4 (4) 
245 -+ 2 (6) 25 20.2 -+ 2.2 (4) 
160-* 3 (5) 4 11.6 ± 1.2 (5) 
185 +- 4 (6) 10 13.0 -+ 2.0 (4) 
212 -+ 3 (3) 25 15.6-+ 1.3 (5) 
adi-S(182,189)-carboxymethylated HGH was obtained from fraction 2 of fig.2.; tetra-S-alkylated HGHs were prepared 
according to Dixon and Li [1 ] and Bewley et al. [2]. 
bMean -+ s.e.m.; number of animals is indicated in parentheses. 
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3. Discussion 
It is apparent from table 2 that reduced and 
di-S(182,189)-carboxymethylated HGH retains the 
full biological potency of native HGH as measured 
by the rat ibia and pigeon crop-sac tests. Our assay 
data on the completely reduced and alkylated HGH 
derivatives confirm the earlier results of Li and co- 
workers [1-4]  : complete reduction and carboxy- 
methylation of both disulfide bonds in HGH abolishes 
the growth promoting activity of the hormone [3], 
whereas reduction and carbamidomethylation of the 
disulfide bridges do not alter the biological properties 
of HGH [1 -4] .  The slight biological activity of tetra- 
S-carboxymethylated HGH prepared according to 
Bewley et al. [2] (table 2) may be due to the presence 
of a small amount of contaminating di-S(182,189)- 
carboxymethylated HGH in this preparation (see 
tube f in fig.3). 
The full biological potency of di-S(182,189)- 
carboxymethylated HGH together with t e abolished 
activity of tetra-S-carboxymethylated HGH suggest 
that the reduction and carboxymethylation f the 
disulfide bond between Cyss3-Cys16s in the HGH 
structure is responsible for the loss of biological 
activity. The inactivating effect of the carboxy- 
methyl groups introduced on the cysteinyl residues 
at sequence positions 53 and 165 of HGH may be 
due to an electrostatic repulsion between these 
groups which weakens or destroys the interaction 
between the two cysteine-containing portions of the 
molecule. The importance of such interaction(s) for 
the full biological potency of HGH has also beer 
pointed out by Li and Grfif [13]. 
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